However, clinical reports show that SALL2 is upregulated in other cancer types, such as glioblastoma and synovial sarcoma, suggesting an oncogenic role (Li et al., 2002; Nielsen et al., 2003; Estilo et al., 2009; Suvà et al., 2014). This evidence concerns the gene SALL2 and cancer.